# A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy

> **NCT03043807** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 26 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Leuprolide Acetate
- **DRUG:** Docetaxel
- **DRUG:** Bicalutamide
- **RADIATION:** Radiation
- **DRUG:** Abiraterone Acetate

## Key facts

- **NCT ID:** NCT03043807
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-22
- **Primary completion:** 2022-10-17
- **Final completion:** 2022-10-17
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043807, "A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03043807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*